| IDL | Index to Dental Literature; interface definition language; intermediate density lipoprotein; interme... |
|---|---|
| IDL | Intermediate Density Lipoprotein; 중밀도 지질 단백질 |
| IF | idiopathic fibroplasia; idiopathic flushing; immersion foot; immunofluorescence; indirect fluorescen... |
| IM | idiopathic myelofibrosis; immunosuppressive method; implementation monitoring; Index Medicus; indome... |
| HDL | High Density Lipoprotein; 고밀도 지질 단백질 |
| IDL | Intermediate Density Lipoprotein |
|---|---|
| LDL-C | lipoprotein cholesterol and low-density lipoprotein cholesterol |
| IDL | intermediate density |
| LDL | 125I-low density lipoprotein |
| HDL | A-high-density lipoprotein |
corticotropin-releasing factor (부신 피질 호르몬 유리 요소, 부신 피질 호르몬 유리 인자
| intermediate density lipoprotein | Class of lipoproteins formed in degradation of very-low-density lipoproteins; about half are cleared quickly from the plasma into the liver by receptor-mediated endocytosis; the other half are degraded into low density lipoproteins. (05 Mar 2000) |
|---|
| very low density lipoprotein | <biochemistry> A lipoprotein substances (combination of a fat and a protein) which acts as a carrier for cholesterol and fats (particularly triglycerides) in the bloodstream. Elevations in very low density lipoprotein in the bloodstream are associated with an increased risk of atherosclerosis and coronary artery disease. Acronym: VLDL (18 Nov 1997) |
|---|---|
| high density lipoprotein | <biochemistry> These lipoproteins acts to carry cholesterol in the bloodstream. Raised high density lipoprotein levels have been correlated with a lower risk for heart disease. Less than 35 mg/dl is considered a positive risk factor for coronary artery disease, over 60 mg/dl is considered a negative risk factor (reduces your risk of heart disease). Recent studies show a low high density lipoprotein level is the strongest predictor of cardiovascular death in women. Acronym: HDL (18 Nov 1997) |
| familial high density lipoprotein deficiency | Familial high {density lipoprotein deficiency}; a heritable disorder of lipid metabolism characterised by almost complete absence from plasma of high density lipoproteins, and by storage of cholesterol esters in foam cells, tonsillar enlargement, an orange or yellow-gray colour of the pharyngeal and rectal mucosa, hepatosplenomegaly, lymph node enlargement, corneal opacity, and peripheral neuropathy; autosomal recessive inheritance. Synonym: familial high {density lipoprotein deficiency}, Tangier disease. Origin: G. An-, priv., + alpha, a, + lipoprotein + -aemia, blood (05 Mar 2000) |
| low density lipoprotein | <biochemistry> A lipoprotein substances (combination of a fat and a protein) which acts as a carrier for cholesterol and fats in the bloodstream. High levels of low density lipoprotein are considered a positive risk factor for the development of coronary artery disease. Less than 130 mg/dl is desirable, 130 to 159 mg/dl is borderline high, over 160 is considered high. Acronym: LDL (10 Jan 1998) |
| low density lipoprotein receptor | <biochemistry> A cell surface protein that mediates the endocytosis of low density lipoprotein by cells. Genetic defects in low density lipoprotein receptors lead to abnormal serum levels of low density lipoprotein and hypercholesterolaemia. (16 Mar 1998) |
| low-density lipoprotein receptors | Receptors on the surface of cells, especially liver cells, which bind to low density lipoprotein and promote clearance of LDL from the plasma. (05 Mar 2000) |
| a1-lipoprotein | A lipoprotein fraction of relatively low molecular weight, high density, rich in phospholipids, and found in the a1-globulin fraction of human plasma. (05 Mar 2000) |
| b1-lipoprotein | A lipoprotein fraction of relatively high molecular weight, low density, rich in cholesterol, and found in the beta-globulin fraction of human plasma. (05 Mar 2000) |
| receptors, lipoprotein | Cell surface proteins that bind lipoproteins with high affinity. Lipoprotein receptors in the liver and peripheral tissues mediate the regulation of plasma and cellular cholesterol metabolism and concentration. The receptors generally recognise the apolipoproteins of the lipoprotein complex, and binding is often a trigger for endocytosis. (12 Dec 1998) |
| multiple lipoprotein-type hyperlipidaemia | <biochemistry> Inherited as a defective gene, this disorder is characterised by elevations in serum cholesterol and/or triglycerides. There are often multiple types of lipoproteins (LDL) elevated in one family. This condition is associated with an increased risk of cardiovascular disease. Origin: Gr. Haima = blood (27 Sep 1997) |
| familial lipoprotein lipase deficiency | An rare inherited disorder where there is a deficiency of an enzyme (lipoprotein lipase) which breaks down fat molecules, causing the accumulation of fats or lipoproteins in the blood. Symptoms in infancy include abdominal pain (appears as if its colic), failure to thrive and skin lesions (xanthomas). (27 Sep 1997) |
| familial lipoprotein lipase inhibitor | An inhibitor found in certain individuals that inhibits lipoprotein lipase resulting in accumulation of chylomicrons, VLDL, and triacylglycerols; similar in symptoms to familial lipoprotein lipase deficiency. (05 Mar 2000) |
| lipoprotein | <biochemistry> An important class of serum proteins in which a spherical hydrophobic core of triglycerides or cholesterol esters surrounded by an amphipathic monolayer of phospholipids, cholesterol and apolipoproteins. Classified according to density: chylomicrons, large low density particles, very low density, low density and high density species. Important in lipid transport, especially cholesterol transport in the blood stream. Abnormalities in lipoprotein metabolism have been implicated in certain heart diseases. (13 Nov 1997) |
| lipoprotein(a) | A family of lipoprotein particles varying in density and size depending on the protein-lipid ratio and the protein composition. These particles consist of apolipoprotein b-100 covalently linked to apolipoprotein-a by one or two disulfide bonds. There is a correlation between high plasma levels of this lipoprotein and increased risk for atherosclerotic cardiovascular disease. (12 Dec 1998) |
| lipoprotein(a) hyperlipoproteinaemia | Elevated levels of lipoprotein(a) in the serum; associated with an increased risk of coronary disease. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|